Type of leukemia-Acute Lymphoblastic Leukemia (ALL) - Page 2 of 7 Posts on Medivizor
Navigation Menu

Type of leukemia-Acute Lymphoblastic Leukemia (ALL) Posts on Medivizor

Cardiac function of survivors of childhood acute lymphoblastic leukemia treated with anthracyclines

Cardiac function of survivors of childhood acute lymphoblastic leukemia treated with anthracyclines

Posted by on Aug 9, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the heart function of acute lymphoblastic leukemia survivors who had been treated with anthracyclines. This study concluded that these patients had decreased heart function long after treatment. Some background Anthracyclines are a type of chemotherapy drug. Examples are daunorubicin...

Read More

Long term outcomes for children with acute lymphoblastic leukemia treated with the SCMC-ALL-2009 protocol

Long term outcomes for children with acute lymphoblastic leukemia treated with the SCMC-ALL-2009 protocol

Posted by on Jul 26, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the long-term treatment outcomes and prognostic factors of acute lymphoblastic leukemia (ALL) in pediatric patients who took part in the SCMC-ALL-2009 trials.   This study concluded that the long-term outcomes were favorable for these patients and better for low-risk patients...

Read More

Impact of graft cryopreservation on allogeneic hematopoietic stem cell transplant outcomes using post-transplant cyclophosphamide

Impact of graft cryopreservation on allogeneic hematopoietic stem cell transplant outcomes using post-transplant cyclophosphamide

Posted by on Jun 21, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to compare outcomes of allogeneic hematopoietic stem cell transplant (alloHSCT) using cryopreserved (frozen) and fresh grafts in patients with blood cancers who received post-transplant cyclophosphamide (Cytoxan). This study concluded that cryopreservation (CP) does not affect the outcomes of HSCT in these patients....

Read More

Impact of graft cryopreservation on allogeneic hematopoietic stem cell transplant outcomes using post-transplant cyclophosphamide

Impact of graft cryopreservation on allogeneic hematopoietic stem cell transplant outcomes using post-transplant cyclophosphamide

Posted by on Jun 21, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to compare outcomes of allogeneic hematopoietic stem cell transplant (alloHSCT) using cryopreserved (frozen) and fresh grafts in patients with blood cancers who received post-transplant cyclophosphamide (Cytoxan).   This study concluded that cryopreservation (CP) does...

Read More

The occurrence of cardiac autonomic dysfunction in patients who survived childhood acute lymphoblastic leukemia

The occurrence of cardiac autonomic dysfunction in patients who survived childhood acute lymphoblastic leukemia

Posted by on May 31, 2020 in Leukemia | 0 comments

In a nutshell The study evaluated occurrence, risk-factor, and exercise response of cardiac autonomic dysfunction (CAD) in adult survivors of childhood acute lymphoblastic leukemia (ALL). The authors found that over one-third of survivors developed CAD. It was related to lower exercise capacity. Some background Survivors of childhood ALL have reduced...

Read More

Maintenance treatment impact on sleep-wake rhythms and cancer-related fatigue in children with acute lymphoblastic leukemia

Maintenance treatment impact on sleep-wake rhythms and cancer-related fatigue in children with acute lymphoblastic leukemia

Posted by on May 16, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the impact of maintenance treatment on cancer-related fatigue and sleep-wake rhythms in pediatric patients with acute lymphoblastic leukemia.   This study concluded that sleep-wake rhythms are disturbed, physical activity levels lower and cancer-related fatigue levels higher...

Read More

The effects of continued blinatumomab therapy in adult patients with relapsed/refractory acute lymphoblastic leukemia

Posted by on May 3, 2020 in Leukemia | 0 comments

In a nutshell The study evaluated treatment outcomes in patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) who continued blinatumomab (Blincyto; BL) after initial therapy. The authors found that long-term BL therapy can improve survival in these patients. Some background 45% of adults with ALL experience R/R...

Read More

Monitoring of asparaginase treatments for childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma

Posted by on Mar 27, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the activity of two types of asparaginase drugs in pediatric patients with acute lymphoblastic leukemia or non-Hodgkin lymphoma. This study concluded that this type of treatment needs close monitoring for optimal effectiveness. Some background Asparaginase (ASNase) is a drug used in the treatment of...

Read More

The treatment of standard-risk B-cell acute lymphoblastic leukemia with intensified postinduction therapy

Posted by on Dec 29, 2019 in Leukemia | 0 comments

In a nutshell This study evaluated if the intensified postinduction therapy is safe and effective to treat children with standard-risk (SR) B-cell acute lymphoblastic leukemia (B-ALL). The study concluded that the treatment excellently impacted survival among patients, but further intensifying the therapy might be unnecessary. Some background B-ALL is...

Read More